|
Q
|
Mcs29
|
Mammary carcinoma susceptibility QTL 29
|
|
IDA
|
| |
|
|
RGD |
PMID:21205740 |
RGD:5684388 |
NCBI chr 5:38,004,331...83,004,331
|
|
Q
|
Mcs30
|
Mammary carcinoma susceptibility QTL 30
|
|
IDA
|
| |
8.62
|
|
RGD |
PMID:24023717 |
RGD:7327193 |
NCBI chr12:5,633,306...50,633,306
|
|
Q
|
Mcs31
|
Mammary carcinoma susceptibility QTL 31
|
|
IDA
|
| |
2.98
|
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 9:85,262,459...118,999,486
|
|
Q
|
Mcs32
|
Mammary carcinoma susceptibility QTL 32
|
|
IDA
|
| |
2.61
|
|
RGD |
PMID:23967281 |
RGD:7794780 |
|
|
Q
|
Mcs33
|
Mammary carcinoma susceptibility QTL 33
|
|
IDA
|
| |
1.93
|
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 5:136,631,198...172,190,305
|
|
Q
|
Mcs34
|
Mammary carcinoma susceptibility QTL 34
|
|
IDA
|
| |
1.54
|
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr18:65,635,567...85,897,775
|
|
|
Q
|
Emca1
|
Estrogen-induced mammary cancer QTL 1
|
|
IAGP
|
| |
4.4
|
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr 5:104,262,817...153,890,625
|
|
Q
|
Emca11
|
Estrogen-induced mammary cancer QTL 11
|
|
IDA
|
| |
|
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:73,176,602...118,176,602
|
|
Q
|
Emca12
|
Estrogen-induced mammary cancer QTL 12
|
|
IDA
|
| |
|
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:94,034,903...139,034,903
|
|
Q
|
Emca13
|
Estrogen-induced mammary cancer QTL 13
|
|
IDA
|
| |
|
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:14,606,078...59,606,078
|
|
Q
|
Emca2
|
Estrogen-induced mammary cancer QTL 2
|
|
IAGP
|
| |
1.6
|
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr18:65,846,447...86,134,022
|
|
Q
|
Emca4
|
Estrogen-induced mammary cancer QTL 4
|
susceptibility
|
IDA
|
| |
3.7
|
estrogen induced
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 7:63,889,858...108,889,858
|
|
Q
|
Emca5
|
Estrogen-induced mammary cancer QTL 5
|
susceptibility
|
IDA
|
| |
3.9
|
estrogen induced
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 3:145,335,553...189,428,310
|
|
Q
|
Emca6
|
Estrogen-induced mammary cancer QTL 6
|
susceptibility
|
IDA
|
| |
5.8
|
estrogen induced
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 4:45,429,709...157,555,683
|
|
Q
|
Emca7
|
Estrogen-induced mammary cancer QTL 7
|
|
IDA
|
| |
4.0
|
estrogen induced
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 6:20,859,430...113,082,285
|
|
Q
|
Emca8
|
Estrogen-induced mammary cancer QTL 8
|
susceptibility
|
IDA
|
| |
4.1
|
estrogen induced
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 5:55,124,766...172,190,305
|
|
Q
|
Mamtr5
|
Mammary tumor resistance QTL 5
|
|
IDA
|
| |
|
|
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr 5:23,671,493...68,671,493
|
|
Q
|
Mamtr6
|
Mammary tumor resistance QTL 6
|
|
IDA
|
| |
|
|
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr18:19,553,532...85,493,247
|
|
Q
|
Mamtr7
|
Mammary tumor resistance QTL 7
|
|
IDA
|
| 0.003 |
|
|
RGD |
PMID:19052818 |
RGD:2302423 |
|
|
Q
|
Mamtr8
|
Mammary tumor resistance QTL 8
|
|
IDA
|
| 0.001 |
|
|
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr18:31,610,505...85,493,247
|
|
Q
|
Mcs1
|
Mammary carcinoma susceptibility QTL 1
|
|
QTM
|
| |
4.4
|
|
RGD |
PMID:8168109 |
RGD:61080 |
NCBI chr 2:9,623,581...25,054,526
|
|
Q
|
Mcs15
|
Mammary carcinoma susceptibility QTL 15
|
|
IAGP
|
| |
4.5
|
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr10:72,724,423...107,713,808
|
|
Q
|
Mcs16
|
Mammary carcinoma susceptibility QTL 16
|
|
IDA
|
| |
2.4
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 1:1...26,564,886
|
|
Q
|
Mcs17
|
Mammary carcinoma susceptibility QTL 17
|
|
IDA
|
| |
3.0
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 1:207,099,883...252,099,883
|
|
Q
|
Mcs18
|
Mammary carcinoma susceptibility QTL 18
|
|
IDA
|
| |
2.6
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 2:9,623,581...44,538,110
|
|
Q
|
Mcs19
|
Mammary carcinoma susceptibility QTL 19
|
|
IDA
|
| |
2.5
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 5:82,032,155...127,032,155
|
|
Q
|
Mcs2
|
Mammary carcinoma susceptibility QTL 2
|
|
QTM
|
| |
3.38
|
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 7:20,920,494...37,412,865
|
|
Q
|
Mcs20
|
Mammary carcinoma susceptibility QTL 20
|
|
IDA
|
| |
3.0
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 9:21,031,430...49,025,574
|
|
Q
|
Mcs21
|
Mammary carcinoma susceptibility QTL 21
|
|
IDA
|
| |
3.0
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr10:29,377,046...52,699,134
|
|
Q
|
Mcs22
|
Mammary carcinoma susceptibility QTL 22
|
|
IDA
|
| |
3.3
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
|
|
Q
|
Mcs23
|
Mammary carcinoma susceptibility QTL 23
|
|
IDA
|
| |
|
|
RGD |
PMID:17404222 |
RGD:1601189 |
|
|
Q
|
Mcs24
|
Mammary carcinoma susceptibility QTL 24
|
|
IDA
|
| |
|
|
RGD |
PMID:17404222 |
RGD:1601189 |
NCBI chr 5:69,835,120...114,835,120
|
|
Q
|
Mcs26
|
Mammary carcinoma susceptibility QTL 26
|
|
IDA
|
| 1.0E-4 |
|
DMBA induced
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr 6:112,483,610...147,156,653
|
|
Q
|
Mcs27
|
Mammary carcinoma susceptibility QTL 27
|
|
IDA
|
| 1.0E-4 |
|
DMBA induced
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr13:45,990,077...50,392,939
|
|
Q
|
Mcs3
|
Mammary carcinoma susceptibility QTL 3
|
|
QTM
|
| |
2.15
|
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 1:111,404,407...142,582,336
|
|
Q
|
Mcs4
|
Mammary carcinoma susceptibility QTL 4
|
|
QTM
|
| |
1.1
|
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 8:44,475,043...89,475,043
|
|
Q
|
Mcs5
|
Mammary carcinoma susceptibility QTL 5
|
|
QTM
|
| |
10.51
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 5:60,601,597...137,492,949
|
|
Q
|
Mcs6
|
Mammary carcinoma susceptibility QTL 6
|
|
QTM
|
| |
2.29
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 7:28,624,575...65,788,017
|
|
Q
|
Mcs7
|
Mammary carcinoma susceptibility QTL 7
|
|
QTM
|
| |
2.38
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr10:72,724,423...107,713,808
|
|
Q
|
Mcs8
|
Mammary carcinoma susceptibility QTL 8
|
|
QTM
|
| |
4.28
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr14:3,957,878...24,886,169
|
|
Q
|
Mcsm1
|
Mammary carcinoma susceptibility modifier QTL 1
|
|
QTM
|
| |
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 6:64,367,996...109,367,996
|
|